132 related articles for article (PubMed ID: 11334388)
41. Spectrum of the KIT Gene Mutations in Gastrointestinal Stromal Tumors in Arab Patients.
Faiyaz-Ul-Haque M; Al-Dayel F; Tulba A; Abalkhail H; Alhussaini H; Memon M; Bazarbashi S; Amin T; Satti MB; Peltekova I; Nawaz Z; Zaidi SH
Asian Pac J Cancer Prev; 2018 Oct; 19(10):2905-2910. PubMed ID: 30362320
[TBL] [Abstract][Full Text] [Related]
42. [A case of gastric GIST treated preoperatively by imatinib mesylate].
Hiramatsu Y; Konno H; Kamiya K; Baba M; Ohta M; Kondo K; Yamamoto M; Kikuchi H; Tanaka T; Sugimura H; Nakamura S
Gan To Kagaku Ryoho; 2004 Aug; 31(8):1219-23. PubMed ID: 15332547
[TBL] [Abstract][Full Text] [Related]
43. Two cases of gastrointestinal stromal tumor of the stomach with lymph node metastasis.
Sato T; Kanda T; Nishikura K; Hirota S; Hashimoto K; Nahagawa S; Ohashi M; Hatakeyama K
Hepatogastroenterology; 2007 Jun; 54(76):1057-60. PubMed ID: 17629038
[TBL] [Abstract][Full Text] [Related]
44. Characteristics of KIT-negative gastrointestinal stromal tumours and diagnostic utility of protein kinase C theta immunostaining.
Lee HE; Kim MA; Lee HS; Lee BL; Kim WH
J Clin Pathol; 2008 Jun; 61(6):722-9. PubMed ID: 18381383
[TBL] [Abstract][Full Text] [Related]
45. Gastrointestinal stromal tumors with exon 8 c-kit gene mutation might occur at extragastric sites and have metastasis-prone nature.
Ito T; Yamamura M; Hirai T; Ishikawa T; Kanda T; Nakai T; Ohkouchi M; Hashikura Y; Isozaki K; Hirota S
Int J Clin Exp Pathol; 2014; 7(11):8024-31. PubMed ID: 25550846
[TBL] [Abstract][Full Text] [Related]
46. Small gastrointestinal stromal tumor in the stomach: identification of precursor for clinical gastrointestinal stromal tumor using c-kit and α-smooth muscle actin expression.
Mikami T; Nemoto Y; Numata Y; Hana K; Nakada N; Ichinoe M; Murakumo Y; Okayasu I
Hum Pathol; 2013 Dec; 44(12):2628-35. PubMed ID: 24119563
[TBL] [Abstract][Full Text] [Related]
47. Prognostic value of KIT mutation type, mitotic activity, and histologic subtype in gastrointestinal stromal tumors.
Singer S; Rubin BP; Lux ML; Chen CJ; Demetri GD; Fletcher CD; Fletcher JA
J Clin Oncol; 2002 Sep; 20(18):3898-905. PubMed ID: 12228211
[TBL] [Abstract][Full Text] [Related]
48. Gastrointestinal stromal tumors (GISTs) with KIT and PDGFRA mutations have distinct gene expression profiles.
Subramanian S; West RB; Corless CL; Ou W; Rubin BP; Chu KM; Leung SY; Yuen ST; Zhu S; Hernandez-Boussard T; Montgomery K; Nielsen TO; Patel RM; Goldblum JR; Heinrich MC; Fletcher JA; van de Rijn M
Oncogene; 2004 Oct; 23(47):7780-90. PubMed ID: 15326474
[TBL] [Abstract][Full Text] [Related]
49. Gastrointestinal stromal tumors: overview of pathologic features, molecular biology, and therapy with imatinib mesylate.
Koh JS; Trent J; Chen L; El-Naggar A; Hunt K; Pollock R; Zhang W
Histol Histopathol; 2004 Apr; 19(2):565-74. PubMed ID: 15024716
[TBL] [Abstract][Full Text] [Related]
50. Cytogenetic confirmation of a gastrointestinal stromal tumor and ewing sarcoma/primitive neuroectodermal tumor in a single patient.
Kondo S; Yamaguchi U; Sakurai S; Ikezawa Y; Chuman H; Tateishi U; Furuta K; Hasegawa T
Jpn J Clin Oncol; 2005 Dec; 35(12):753-6. PubMed ID: 16332719
[TBL] [Abstract][Full Text] [Related]
51. KIT mutation portends poor prognosis in gastrointestinal stromal/smooth muscle tumors.
Ernst SI; Hubbs AE; Przygodzki RM; Emory TS; Sobin LH; O'Leary TJ
Lab Invest; 1998 Dec; 78(12):1633-6. PubMed ID: 9881963
[TBL] [Abstract][Full Text] [Related]
52. Epithelioid gastrointestinal stromal tumor of the stomach with liver metastases in a 12-year-old girl: aspiration cytology and molecular study.
Li P; Wei J; West AB; Perle M; Greco MA; Yang GC
Pediatr Dev Pathol; 2002; 5(4):386-94. PubMed ID: 12198577
[TBL] [Abstract][Full Text] [Related]
53. Gastric GI stromal tumors (GISTs): the role of surgery in the era of targeted therapy.
Heinrich MC; Corless CL
J Surg Oncol; 2005 Jun; 90(3):195-207; discussion 207. PubMed ID: 15895440
[TBL] [Abstract][Full Text] [Related]
54. Mutations of c-kit JM domain are found in a minority of human gastrointestinal stromal tumors.
Moskaluk CA; Tian Q; Marshall CR; Rumpel CA; Franquemont DW; Frierson HF
Oncogene; 1999 Mar; 18(10):1897-902. PubMed ID: 10086344
[TBL] [Abstract][Full Text] [Related]
55. The novel marker, DOG1, is expressed ubiquitously in gastrointestinal stromal tumors irrespective of KIT or PDGFRA mutation status.
West RB; Corless CL; Chen X; Rubin BP; Subramanian S; Montgomery K; Zhu S; Ball CA; Nielsen TO; Patel R; Goldblum JR; Brown PO; Heinrich MC; van de Rijn M
Am J Pathol; 2004 Jul; 165(1):107-13. PubMed ID: 15215166
[TBL] [Abstract][Full Text] [Related]
56. Gastric GISTs: Analysis of c-Kit, PDGFRA and BRAF mutations in relation to prognosis and clinical pathological characteristics of patients - A GIRCG study.
Capelli L; Petracci E; Quagliuolo V; Saragoni L; Colombo P; Morgagni P; Calistri D; Tomezzoli A; Di Cosmo M; Roviello F; Vindigni C; Coniglio A; Villanacci V; Catarci M; Coppola L; Alfieri S; Ricci R; Capella C; Rausei S; Gulino D; Amadori D; Ulivi P;
Eur J Surg Oncol; 2016 Aug; 42(8):1206-14. PubMed ID: 27265040
[TBL] [Abstract][Full Text] [Related]
57. Gastrointestinal stromal tumor of the rectum with activating mutation of c-kit: report of a case.
Kurokawa Y; Nishisho I; Kawahara K; Mishima H; Hirota S; Kikkawa N
Dis Colon Rectum; 2000 Sep; 43(9):1316-8. PubMed ID: 11005505
[TBL] [Abstract][Full Text] [Related]
58. A missense mutation in KIT kinase domain 1 correlates with imatinib resistance in gastrointestinal stromal tumors.
Chen LL; Trent JC; Wu EF; Fuller GN; Ramdas L; Zhang W; Raymond AK; Prieto VG; Oyedeji CO; Hunt KK; Pollock RE; Feig BW; Hayes KJ; Choi H; Macapinlac HA; Hittelman W; Velasco MA; Patel S; Burgess MA; Benjamin RS; Frazier ML
Cancer Res; 2004 Sep; 64(17):5913-9. PubMed ID: 15342366
[TBL] [Abstract][Full Text] [Related]
59. Imatinib mesylate: in the treatment of gastrointestinal stromal tumours.
Croom KF; Perry CM
Drugs; 2003; 63(5):513-22; discussion 523-4. PubMed ID: 12600228
[TBL] [Abstract][Full Text] [Related]
60. Deletion of Trp-557 and Lys-558 in the juxtamembrane domain of the c-kit protooncogene is associated with metastatic behavior of gastrointestinal stromal tumors.
Wardelmann E; Losen I; Hans V; Neidt I; Speidel N; Bierhoff E; Heinicke T; Pietsch T; Büttner R; Merkelbach-Bruse S
Int J Cancer; 2003 Oct; 106(6):887-95. PubMed ID: 12918066
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
